RecruitingNCT05376254

3D Assessment of RV Function in Patients Undergoing LVAD Implantation

Three-Dimensional Assessment of Right Ventricular Function in Patients Undergoing Left Ventricular Assist Device Implantation

Sponsor

University of Alberta

Enrollment

200 participants

Start Date

Mar 22, 2022

Study Type

OBSERVATIONAL

Conditions

Heart Failure

Summary

This goal of this study is to analyze images of the right ventricle taken via 3D transesophageal echocardiography (TEE) during left ventricular assist device (LVAD) implantation.

Eligibility

Min Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This study is using advanced 3D ultrasound imaging of the heart to better predict which patients might experience right-heart failure after having a mechanical heart pump (called an LVAD) implanted to help their left side of the heart pump. **You may be eligible if...** - You are receiving a mechanical heart pump (HeartMate III, HeartWare HVAD, or CentriMag device) - You have adequate imaging data available for analysis **You may NOT be eligible if...** - Key heart measurements or imaging data needed for the study are missing - You had additional heart valve surgeries at the same time as the pump implant - You also needed a right-heart pump placed at the same time - The ultrasound images obtained were too poor in quality for analysis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.